Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors

Bibliography

• Linder BL. Cortisol production rate in childhood and adolescence. J Pediatr 1990;117:892-6
   PubMed Web of Science ®Google Scholar
• Kraan GP. The daily cortisol production reinvestigated in healthy men. The serum and urinary cortisol production rates are not significantly different. J Clin Endocrinol Metab 1998;83:1247-52
   PubMed Web of Science ®Google Scholar
• Crown A, Lightman S. Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin Endocrinol (Oxf) 2005;63:483-92
   PubMed Web of Science ®Google Scholar
• Dunlop D. Eighty-six cases of Addison's disease. Br Med J 1963;2:887-91
   PubMedGoogle Scholar
• Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003;361:1881-93
   PubMed Web of Science ®Google Scholar
• Wilsson JD, Foster DW, Kronenberg HM, Larsen PR, editors. Williams textbook of endocrinology. London: WB Saunders Company; 1998
   Google Scholar
• Crown A, Lightman S. Management of patients with glucocorticoid deficiency. Nat Clin Pract Endocrinol Metab 2005;1:62-3
   PubMedGoogle Scholar
• Bergthorsdottir R. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 2006;91:4849-53
   PubMed Web of Science ®Google Scholar
• Lovas K, Husebye ES. Continuous subcutaneous hydrocortisone infusion in Addison's disease. Eur J Endocrinol 2007;157:109-12
   PubMed Web of Science ®Google Scholar
• Darzy KH, Shalet SM. Absence of adrenocorticotropin (ACTH) neurosecretory dysfunction but increased cortisol concentrations and production rates in ACTH-replete adult cancer survivors after cranial irradiation for nonpituitary brain tumors. J Clin Endocrinol Metab 2005;90:5217-25
   PubMed Web of Science ®Google Scholar
• Czock D. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 2005;44:61-98
   PubMed Web of Science ®Google Scholar
• Derendorf H. Pharmacokinetics and oral bioavailability of hydrocortisone. J Clin Pharmacol 1991;31:473-6
   PubMed Web of Science ®Google Scholar
• Toothaker RD, Welling PG. Effect of dose size on the pharmacokinetics of intravenous hydrocortisone during endogenous hydrocortisone suppression. J Pharmacokinet Biopharm 1982;10:147-56
   PubMedGoogle Scholar
• Schedl HP. Absorption of steroid hormones from the human small intestine. J Clin Endocrinol Metab 1965;25:1309-16
   PubMed Web of Science ®Google Scholar
• Lennernas H. Intestinal permeability and its relevance for absorption and elimination. Xenobiotica 2007;37:1015-1
   PubMed Web of Science ®Google Scholar
• Yates CR. Structural determinants of P-glycoprotein-mediated transport of glucocorticoids. Pharm Res 2003;20:1794-803
   PubMed Web of Science ®Google Scholar
• Naylor LJ, Bakatselou V, Dressman JB. Comparison of the mechanism of dissolution of hydrocortisone in simple and mixed micelle systems. Pharm Res 1993;10:865-70
   PubMed Web of Science ®Google Scholar
• Faassen F. Physicochemical properties and transport of steroids across Caco-2 cells. Pharm Res 2003;20:177-86
   PubMed Web of Science ®Google Scholar
• Pedersen BL. Dissolution of hydrocortisone in human and simulated intestinal fluids. Pharm Res 2000;17:183-9
   PubMed Web of Science ®Google Scholar
• Ueda K. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem 1992;267:24248-52
   PubMed Web of Science ®Google Scholar
• Karssen AM. Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology 2001;142:2686-94
   PubMed Web of Science ®Google Scholar
• Toothaker RD, Craig WA, Welling PG. Effect of dose size on the pharmacokinetics of oral hydrocortisone suspension. J Pharm Sci 1982;71:1182-5
   PubMed Web of Science ®Google Scholar
• Toothaker RD. Oral hydrocortisone pharmacokinetics: a comparison of fluorescence and ultraviolet high-pressure liquid chromatographic assays for hydrocortisone in plasma. J Pharm Sci 1982;71:573-6
   PubMed Web of Science ®Google Scholar
• Amidon GL. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413-20
   PubMed Web of Science ®Google Scholar
• Basit AW. Advances in colonic drug delivery. Drugs 2005;65:1991-2007
   PubMed Web of Science ®Google Scholar
• Price JM, Davis SS, Wilding IR. Characterization of colonic transit of nondisintegrating tablets in healthy subjects. Dig Dis Sci 1993;38:1015-21
   PubMed Web of Science ®Google Scholar
• Schiller C. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment Pharmacol Ther 2005;22:971-9
   PubMed Web of Science ®Google Scholar
• Hebden JM. Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system. Pharm Res 1999;16:1087-92
   PubMed Web of Science ®Google Scholar
• Price JM. The effect of meal composition on the gastrocolonic response: implications for drug delivery to the colon. Pharm Res 1993;10:722-6
   PubMed Web of Science ®Google Scholar
• Coupe AJ, Davis SS, Wilding IR. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm Res 1991;8:360-4
   PubMed Web of Science ®Google Scholar
• Kyriazopoulou V. Glucocorticoid replacement therapy in patients with Addison's disease. Expert Opin Pharmacother 2007;8:725-9
   PubMed Web of Science ®Google Scholar
• Mah PM. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 2004;61:367-75
   PubMed Web of Science ®Google Scholar
• Howlett TA. An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol (Oxf) 1997;46:263-8
   PubMed Web of Science ®Google Scholar
• Hong Y. Population pharmacokinetic/pharmacodynamic modeling of systemic corticosteroid inhibition of whole blood lymphocytes: modeling interoccasion pharmacodynamic variability. Pharm Res 2007;24:1088-97
   PubMed Web of Science ®Google Scholar
• Peacey SR. Glucocorticoid replacement therapy: are patients over treated and does it matter? Clin Endocrinol (Oxf) 1997;46:255-61
   PubMed Web of Science ®Google Scholar
• Filipsson H. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab 2006;91:3954-61
   PubMed Web of Science ®Google Scholar
• Fleisher D. Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications. Clin Pharmacokinet 1999;36:233-54
   PubMed Web of Science ®Google Scholar
• Blomgren J. Non-physiological levels of circulating cortisol in growth hormone-treated hypopituitary adults after conventional cortisone substitution. Scand J Clin Lab Invest 2004;64:132-9
   PubMed Web of Science ®Google Scholar
• Esteban NV. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 1991;72:39-45
   PubMed Web of Science ®Google Scholar
• Merza Z. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 2006;65:45-50
   PubMed Web of Science ®Google Scholar
• Tucker GT, Houston JB, Huang SM. EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential: towards a consensus. European Federation of Pharmaceutical Sciences. Eur J Pharm Sci 2001;13:417-28
   PubMedGoogle Scholar
• Newell-Price J. Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers. Clin Endocrinol (Oxf) 2008;68:130-5
   PubMed Web of Science ®Google Scholar
• Shah VP. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. Eur J Drug Metab Pharmacokinet 1991;16:249-55
   PubMed Web of Science ®Google Scholar
• Rees WD. Interdigestive motor activity in patients with systemic sclerosis. Gastroenterology 1982;83:575-80
   PubMed Web of Science ®Google Scholar
• Rees WD. Human interdigestive and postprandial gastrointestinal motor and gastrointestinal hormone patterns. Dig Dis Sci 1982;27:321-9
   PubMed Web of Science ®Google Scholar
• Kellow JE. Human interdigestive motility: variations in patterns from esophagus to colon. Gastroenterology 1986;91:386-95
   PubMed Web of Science ®Google Scholar
• Langguth P. Variable gastric emptying and discontinuities in drug absorption profiles: dependence of rates and extent of cimetidine absorption on motility phase and pH. Biopharm Drug Dispos 1994;15:719-46
   PubMed Web of Science ®Google Scholar
• Oberle RL. The influence of the interdigestive migrating myoelectric complex on the gastric emptying of liquids. Gastroenterology 1990;99:1275-82
   PubMed Web of Science ®Google Scholar
• Coupe AJ. Correlation of the gastric emptying of nondisintegrating tablets with gastrointestinal motility. Pharm Res 1991;8:1281-5
   PubMed Web of Science ®Google Scholar
• Weitschies W. Impact of the intragastric location of extended release tablets on food interactions. J Control Release 2005;108:375-85
   PubMed Web of Science ®Google Scholar
• Renwick AG. The influence of posture on the pharmacokinetics of orally administered nifedipine. Br J Clin Pharmacol 1992;34:332-6
   PubMed Web of Science ®Google Scholar
• Burn-Murdoch R, Fisher MA, Hunt JN. Does lying on the right side increase the rate of gastric emptying? J Physiol 1980;302:395-8
   PubMed Web of Science ®Google Scholar
• Brogna A. Influence of aging on gastrointestinal transit time. An ultrasonographic and radiologic study. Invest Radiol 1999;34:357-9
   PubMed Web of Science ®Google Scholar
• Madsen JL, Graff J. Effects of ageing on gastrointestinal motor function. Age Ageing 2004;33:154-9
   PubMed Web of Science ®Google Scholar
• Cusack BJ. Pharmacokinetics in older persons. Am J Geriatr Pharmacother 2004;2:274-302
   PubMedGoogle Scholar
• Bogentoft C. Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms. Eur J Clin Pharmacol 1978;14:351-5
   PubMed Web of Science ®Google Scholar
• Meyer JH. Human postprandial gastric emptying of 1-3-millimeter spheres. Gastroenterology 1988;94:1315-25
   PubMed Web of Science ®Google Scholar
• Mayer EA. Gastric emptying and sieving of solid food and pancreatic and biliary secretions after solid meals in patients with nonresective ulcer surgery. Gastroenterology 1984;87:1264-71
   PubMed Web of Science ®Google Scholar
• Pal A, Brasseur JG, Abrahamsson B. A stomach road or ‘Magenstrasse’ for gastric emptying. J Biomech 2007;40:1202-10
   PubMed Web of Science ®Google Scholar
• Kerlin P, Phillips S. Variability of motility of the ileum and jejunum in healthy humans. Gastroenterology 1982;82:694-700
   PubMed Web of Science ®Google Scholar
• Kerlin P, Zinsmeister A, Phillips S. Relationship of motility to flow of contents in the human small intestine. Gastroenterology 1982;82:701-6
   PubMed Web of Science ®Google Scholar
• Christensen FN. The use of gamma scintigraphy to follow the gastrointestinal transit of pharmaceutical formulations. J Pharm Pharmacol 1985;37:91-5
   PubMed Web of Science ®Google Scholar
• Davis SS, Hardy JG, Fara JW. Transit of pharmaceutical dosage forms through the small intestine. Gut 1986;27:886-92
   PubMed Web of Science ®Google Scholar
• Narducci F. Twenty four hour manometric recording of colonic motor activity in healthy man. Gut 1987;28:17-25
   PubMed Web of Science ®Google Scholar
• Hebden JM. Night-time quiescence and morning activation in the human colon: effect on transit of dispersed and large single unit formulations. Eur J Gastroenterol Hepatol 1999;11:1379-85
   PubMed Web of Science ®Google Scholar
• Valenzuela GA. Reversibility of gastric dysmotility in cortisol deficiency. Am J Gastroenterol 1987;82:1066-8
   PubMed Web of Science ®Google Scholar
• Valenzuela G. Primary adrenal insufficiency: a new cause of reversible gastric stasis. Am J Gastroenterol 1990;85:1626-8
   PubMed Web of Science ®Google Scholar
• Newell-Price J, Whiteman M, Rostami-Hodjegan A, et al. Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers. Clin Endocrinol (Oxf) 2008;68(1):130-5
   PubMed Web of Science ®Google Scholar
• Tromm A. Pharmacokinetics and rectal bioavailability of hydrocortisone acetate after single and multiple administration in healthy subjects and patients. J Clin Pharmacol 2001;41:536-41
   PubMed Web of Science ®Google Scholar
• Hebden JM. Stool water content and colonic drug absorption: contrasting effects of lactulose and codeine. Pharm Res 1999;16:1254-9
   PubMed Web of Science ®Google Scholar